In this session, professor of psychiatry, director of several addiction divisions at Bellevue and NYU, Director of NYU’s Psychedelic Research Group, and Principal Investigator of the NYU Psilocybin Cancer Project, Stephen Ross, will examine in more depth the results of his team’s double-blind/placebo-controlled trials examining the potential efficacy of psilocybin-assisted psychotherapy in individuals with advanced/terminal cancer and psychological/spiritual distress. He will especially focus on how the intensity of the psilocybin induced mystical state positively correlated with improvements in the patients’ mental states and what the implications of this research might be.
This lecture is part of The Art of Dying Conference Lectures & Panel Series Collection recorded at the Art of Dying Conference in NYC in April of 2015
ISBN Digital Download: AOD15L8DD
For the a listing of all the programs from the art of dying conference follow this link here